Navigation Links
NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinson's Disease
Date:6/1/2010

NESS ZIONA, Israel, June 1, 2010 /PRNewswire/ -- NeuroDerm, Ltd. announced today the successful enrollment and dosing in its Phase I clinical trial of ND0611. ND0611, a proprietary drug formula administered via a dermal patch, is designed to maintain continuous therapeutic levodopa concentrations for improving the treatment of Parkinson's disease.

ND0611 increases levodopa bioavailability and extends its effects by administering a novel pharmaceutical. Previous animal studies found that ND0611 modified levodopa pharmacokinetics by (i) increasing levodopa plasma half-life and area-under-the-curve (AUC), (ii) maintaining levodopa plasma concentrations in a typical therapeutic range, and (iii) extending dopaminergic stimulation in the brain. ND0611's mode of action involves an under-exploited levodopa metabolic pathway and has the potential for markedly improving clinical benefits from levodopa (the most effective drug for Parkinson's disease).

This Phase 1 study was conducted in healthy volunteers with the purpose of measuring the safety and tolerability of ND0611 at different doses. Further analysis will be completed to determine the pharmacokinetic profile of levodopa in plasma. The company expects to present the results of this phase 1 study in the second half of 2010.

"The completion of this first step in the clinical development of ND0611 marks an important milestone in the path to develop a new therapeutic alternative for Parkinson's disease patients," said Oded S. Lieberman, PhD, NeuroDerm's Chairman and CEO. "While constant levodopa plasma concentrations achieved through continuous levodopa infusion have been shown to bring significant benefit to Parkinson's patients, these options are generally impractical. In contrast, ND0611
'/>"/>

SOURCE NeuroDerm Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
2. MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment
3. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
4. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
5. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
6. Phonak Successfully Hosts Hearing Care for Adults 2009 Conference
7. Tamaulipas Comparative Wound Healing Test Treatment Successfully Concluded
8. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
9. Guided Delivery Systems, Inc. Successfully Treats First Patient with Mitral Regurgitation
10. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
11. American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New ... companies  What does the future hold for ... Visiongain,s brand new report shows you potential revenues to ... Our 242-page report provides 185 tables, charts, and ... and the future market prospects. Our new study lets ...
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... March 27, 2015 Concord Medical Services ... CCM ), a leading specialty hospital management ... of radiotherapy and diagnostic imaging centers in ... of a purchase agreement under which Concord Medical ... of the Company, agreed to acquire the Fortis ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... Global Health Solutions Corporation (OTCBB: RHSC) and Montana ... have signed a commercial agreement with Telemedicine Africa to ... solutions to the medically underserved population of Africa through ... Telemedicine Africa aim to deliver RHealth Advisor mobile web ...
... NEW YORK, Oct. 19, 2011 The New York eHealth ... awards for individuals who have made tremendous contributions to the ... be presented on the first night of the NYeC Digital ... look forward to bringing together the many people leading the ...
Cached Medicine Technology:Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 2Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 4New York eHealth Collaborative Announces Winners for its Digital Health Conference Gala Awards 2
(Date:3/27/2015)... York, NY (PRWEB) March 27, 2015 ... seeing more plastic surgery patients travel to the Dominican ... Medina. The plastic surgery clinic is turning the medical ... international cosmetic surgery patients — with trustworthy services becoming ... factor when selecting a plastic surgeon. Patients are not ...
(Date:3/27/2015)... While deep learning was the topic of many conversations ... the CEO of one start-up spoke passionately about using fast ... beyond the generally-agreed ceiling of 120 years. , Insilico Medicine, ... 12 companies recognized as the hottest GPU-powered startups in the ... Emerging Companies Summit have business models focused on self-driving ...
(Date:3/27/2015)... 27, 2015 Endure Yoga is launching ... fitness athletes. This new program matches yoga poses with ... post-workout cool down. This program utilizes yoga to improve ... mental focus. , Karen Lefurgy, competitive athlete at ... long before I started Crossfit® training, but quickly, due ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 GrassrootsHealth, ... its Protect Our Children (POC) NOW! vitamin D demonstration ... Medical University of South Carolina (MUSC), and will soon ... be available at no cost to a minimum of ... who live within these two service areas. The project ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 To address their ... issues, Super-Sod spent a year filming this video to explain ... and the shady environment it's often expected to thrive in, ... All plants need light to survive. Anytime a sun-loving plant ... put on a diet. Many homeowners try to amend this ...
Breaking Medicine News(10 mins):Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... from US claim that they have ascertained the element that ... in bones absorbs pressure on the expense of bonds that ... fracturing.// ,The theory is that when a bone is ... of these bonds, preventing the bone from fracturing.Bones have to ...
... College at Dallas report that contact lenses, both ... materials are expected to reduce the possibility of ... available now. Based in part on these findings, ... hyper-oxygen transmissible contact lenses for 30-day continuous wear.// ...
... University of California, chemists have taken snapshots of ... assistant professor of chemistry at the UC Berkeley, ... shorter than the width of a human hair ... have generated great excitement in the opto-electronics community ...
... According to researchers at Peterson Medical College, a strategy ... the Human Immunodeficiency Virus (HIV) out of dormancy in ... from a Samoan rainforest tree, and appears to stimulate ... allows the body's immune system to detect and attack ...
... According to a study, exercise can help older people ... activities such as standing up and walking an impossible ... less likely to lose abilities to perform activities of ... School of Medicine, Texas, this report is the first ...
... to recent finding, researchers have identified a gene that causes ... allow doctors to treat more effectively patients with early stages ... Dr. Rhoda Alani of Johns Hopkins University, found a gene ... melanoma. Id1 blocks a tumor suppressor gene that ordinarily keeps ...
Cached Medicine News:Health News:New contact lens materials 2Health News:Discovery of World’s smallest laser 2Health News:Prostratin- Drug to eradicate HIV 2Health News:Arthritis risk reduced by exercise 2Health News:Gene causes moles to become cancerous 2
Softwear Saline with unique comfort rinsing formula....
Sensitive Eyes sterile saline spray is the preservative-free aerosol saline solution for people with eyes sensitive to preservatives. Used for rinsing soft contact lenses after cleaning or thermal or...
Ultrazyme enzymatic cleaner works in a single step, taking as little as 15 minutes for cleaning....
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Medicine Products: